SEC Form D · filed February 27, 2023
Venatorx Pharmaceuticals, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (24)
Anthony J. Meehan · Malvern, PAExecMartin J. Heidecker · Malvern, PADirectorTimothy J. Haines · Malvern, PADirectorDaniel C. Pevear · Malvern, PAExecMichael C. Diem · Malvern, PADirectorSergei J. Petukhov · Malvern, PADirectorEzra J. Felker · Malvern, PAExecChristopher J. Burns · Malvern, PAExec · DirectorPromus Equity Partners, LLC · Chicago, ILDirectorBenjamin H. Bolanos · Great Neck, NYExecAndrew Firman · Dallas, TXDirectorSteven H. Rosenzweig · Great Neck, NYDirectorIsaac H. Kalish · Great Neck, NYExecWyatt Cavalier · Wilmington, DEExec · DirectorHuber Klaus · denvor, CODirectorMatthew H. Gould · Great Neck, NYExecMatt M. Whelan · Long Island City, NYDirectorDavid M. Langer · Long Island City, NYExec · DirectorJohn Evans Jr · Wesley Chapel, FLDirectorClay Brock · Wilmette, ILDirectorO'Meara Lauren · Franklin, TNExecOrin Wolf · NEW YORK, NYExecArabella FCRE Management, LLC · Alpharetta, GAExecJeff J. Seavey · Houston, TXDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗